Catalani E
Hoechst Marion Roussel, Milan, Italy.
Int J Tuberc Lung Dis. 1999 Nov;3(11 Suppl 3):S289-91; discussion S317-21.
There is a need to better understand the extent of the utilisation of rifampicin in the market, particularly in fixed-dose combinations (FDC).
To review the Indian market of antituberculosis drugs, as this is the largest single market in the world of this therapeutic class.
Review and analysis of the sales data proffered by the Indian market audit. Estimated data relating to public sector product usage were utilised in order to obtain a more complete scenario.
The use of rifampicin-based products is very important in the Indian market of anti-tuberculosis drugs. Particularly common is the use of FDCs, which represent 62% of anti-tuberculosis drugs sold in the private market.
The Indian market for anti-tuberculosis drugs is very large and well integrated. FDCs are widely used. In addition to double- and triple-drug FDCs, four-drug combinations have recently been introduced into the market. The Indian industry also exports raw materials and pharmaceutical specialities.
有必要更好地了解利福平在市场上的使用范围，尤其是在固定剂量复方制剂（FDC）中的使用情况。
对印度抗结核药物市场进行评估，因为该国是全球这一治疗类别中最大的单一市场。
对印度市场审计提供的销售数据进行审查和分析。利用与公共部门产品使用情况相关的估计数据，以获取更完整的情况。
基于利福平的产品在印度抗结核药物市场的使用非常重要。FDC的使用尤其普遍，在私营市场销售的抗结核药物中占62%。
印度抗结核药物市场规模庞大且整合良好。FDC被广泛使用。除了二联和三联药物FDC外，四联药物组合最近也已进入市场。印度制药行业还出口原材料和药品。
Zotero 插件